Author(s)

Adela H. Elamami^1,2

¹Internal Medicine Department, Benghazi University, Benghazi, Libya.
²Diabetes and Endocrine Unit, Hawari Teaching Hospital, Benghazi, Libya.

Serious hyperglycemia is one of the manifestations of COVID-19 infection which increase patient morbidity and mortality especially in patient requiring hospitalization. Consequently, many protocols and algorithms for hospitalized patients with COVID-19 induced hyperglycemia based mainly on recent studies and previous evidence on non-COVID-19 patients were published. Of note nearly all guidelines released by the different COVID-19 committees in Libya don’t include a clear focus on management of in-patient hyperglycemia and maybe this plays a pivotal role in increase our COVID-19 in-hospital mortality. I proposed a simplified approach depending on the released international guidelines to be easily implemented by Libyan health care staff caring about COVID-19 patients and hoping to be accepted by our National Diabetes Committee.

In-Patient Hyperglycemia, COVID-19, Management, Proposed Guideline, Libya

Elamami, A. (2021) Proposed Libyan Guidelines for the Management of Inpatient Hyperglycemia with Corona Virus-19 (COVID-19) Infection. Open Journal of Epidemiology, 11, 237-244. doi: 10.4236/ojepi.2021.113020.